Variable | Without liver metastasis | With liver metastasis | P value |
---|---|---|---|
Total 5-year mortality | 53/119 (45%) | 75/122 (61%) | 0.009 |
Portal HTN | 14/39 (36%) | 21/30 (70%) | 0.007 |
Sinusoidal portal HTN | 2/4 (50%) | 7/9 (78%) | 0.5 |
Peritoneal carcinomatosis | 34/73 (46.5%) | 47/77 (61%) | 0.1 |
CA: Breast cancer | 4/12 (33%) | 16/29 (55%) | 0.3 |
CA: Gastric cancer | 11/24 (46%) | 4/9 (44%) | 1 |
CA: Lung cancer | 15/32 (47%) | 9/16 (56%) | 0.8 |
CA: Ovarian cancer | 8/15 (53%) | 5/5 (100%) | 0.1 |
CA: Pancreatic cancer | 6/14 (43%) | 17/26 (65%) | 0.2 |
CA: Renal cancer | 7/13 (54%) | 8/13 (62%) | 1 |
CA: Colon cancer | 2/9 (22%) | 16/24 (67%) | 0.04 |